While some studies suggest that OGR1 exhibits pro-tumor effects, for instance in melanoma, pancreatic cancer and colorectal cancer [20, 32, 56], others suggest the opposite [31, 45, 60]. This evidence concerns the gene GPR68 and familial pancreatic carcinoma.